Short description:
Immunes system mapping with AI
Drug notes:
Contact us to add description: recruit@workinbiotech.com
Long description:
Immunai is developing AI-powered solutions to revolutionize the discovery and development of immunotherapies. The company's platform integrates single-cell multiomics, machine learning, and big data computing to map the immune system at scale. Immunai's insights are used to identify and validate novel therapeutic targets and to develop new immunotherapies that are more effective and less toxic than existing treatments. Immunai's pipeline includes programs in a variety of therapeutic areas, including cancer, infectious diseases, and autoimmune diseases. The company's lead product candidate, IMI-101, is a small molecule inhibitor of a key checkpoint molecule that is involved in the suppression of the immune system. IMI-101 is currently in Phase 1 clinical trials for the treatment of advanced solid tumors.
Jobs:
Director of Business Development Europe Zurich, Zurich, Switzerland|6 days ago
Director of Business Development Europe Ramat Gan, Tel Aviv District, Israel|6 days ago
Director of Business Development Europe Zürich Metropolitan Area|6 days ago
Computational Biologist New York, NY|33 days ago
Senior Director of Preclinical and Discovery Appli... New York, NY|44 days ago
Associate Scientist II/Scientist I, Immunology New York, NY|51 days ago
Associate Scientist II/Scientist I, Therapeutic A... New York, NY|58 days ago
Single-Cell Deep Learning Scientist Ramat Gan, Tel Aviv District, Israel|62 days ago
Senior Project Manager Ramat Gan, Tel Aviv District, Israel|68 days ago
Director of Business Development New York, US|100+ days ago